A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

Pediatric use of GLP-1 drugs—which the manufacturers and most doctors say ... She says she doesn’t have as much compulsion to ...

Obesity is a chronic, progressive disease that can lead to serious health complications, reduced quality of life, and ...

"GLP-1 dramatically slows food moving through your gut ... Increasing intake of electrolyte minerals lowers hunger in a way that rivals Ozempic. For example, dieters who get the most potassium eat 47% ...

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

Researchers at the Massachusetts Institute of Technology (MIT), led by Giovanni Traverso, developed a microjet system ...

So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you ...

In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth ...

The uptake of GLP-1 has surged since 2022, mainly in US. Read our takeaways from the UBS Evidence Lab survey on key trends in GLP-1 consumer behaviour GLP-1s, also known as glucagon-like peptide 1, ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Trump's pick to head the Department of Health and Human Services has promoted some unconventional — and potentially dangerous ...